ENTITY

Fangzhou (6086 HK)

36
Analysis
Consumer Staples • China
Fangzhou is China's leading AI-driven online chronic disease management platform, offering comprehensive medical services, online retail pharmacy services, and customized content and marketing solutions. These services include online consultations, e-prescriptions, pharmaceutical product sales, and AI-powered health management tools. The company was founded in 2015 and is headquartered in Guangzhou, China.
more
•15 Apr 2026 10:30

HSCI / HK Connect (March 2026) Post-Event Review: What Worked, What Didn't

HK Connect Mar 2026 implementation cycle is completing. ADD reversed the WAI drawdown at implementation. DELETE continuation worked post...

Logo
268 Views
Share
•20 Feb 2026 01:05

HK Connect March 2026: Implementation Forecast and Positioning Framework

March Connect implementation is nearing: we forecast expected ADD/DELETE actions and assess how positioning, crowding, and southbound flows may...

Logo
535 Views
Share
bullish•HashKey
•05 Jan 2026 05:50

HSCI Index Rebalance Preview and Stock Connect (Mar 2026): Many Changes Following Huge IPO Quarter

There could be 74 changes for the HSCI in March. That could result in 64 changes to the Southbound Stock Connect list and also have implications...

Logo
1.5k Views
Share
•21 Dec 2025 10:05

HK Connect Flows Weekly (Dec 19th): Xiaomi, Meituan, Alibaba, Ping An Insurance, Ke, China Mobile

We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Xiaomi, Meituan, Alibaba, Ping An Insurance, Ke, China...

Logo
428 Views
Share
•14 Dec 2025 10:05

HK Connect Flows Weekly (Dec 12th): Xiaomi Inflows & Tencent/Alibaba Outflows

We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Xiaomi, Tencent, CMB, Alibaba, Zhejiang Leapmotor...

Logo
424 Views
Share
x